REQUIREMENTS

• The technology should be ready for early stage clinical trials or sufficiently characterized to begin first in human trials within 3 years of funding inception

• The proposal must be submitted by a TEAM of laboratory and clinical faculty (at least one from each arena) with one designated as the principal investigator (PI)

• The PI and at least one Investigator in each arena should be at the Assistant, Associate or Professor level. Additional Co-Investigators that are not faculty (e.g. Research Associates) may be proposed

• The clinical investigator must be a physician currently engaged in clinical practice

Priority is given to at least one project with a pediatric focus submitted by a PI with a primary or secondary faculty appointment in the Department of Pediatrics.

PROCESS

• Investigators submit a 1-2 page web-based preapplication in early January.
• DTRI reviews the pre-applications, and a selected group of applicants are invited to submit a full application for detailed review.
• Finalists are chosen to deliver an oral presentation prior to final selection.
• Final award is contingent upon agreement to final project plan at a kick-off meeting conducted prior to funding start date.

METRICS- TRANSLATIONAL UNITS

Projects are tracked throughout the funding period based on the aims and project plan proposed in the application. Tracking continues throughout the entire translational life-cycle with assistance provided by the DTRI and collaborators to help achieve and/or determine if additional translational units can be achieved. Examples of Translational Units.